NeuroSense Therapeutics Israeli Company

NeuroSense Therapeutics is a drug development company offering a treatment for patients with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The companys drug, PrimeC, is a unique formulation combining two FDA-approved compounds for unrelated conditions.